A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
Titel:
A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
Auteur:
Kahl, Brad S. Spurgeon, Stephen E. Furman, Richard R. Flinn, Ian W. Coutre, Steven E. Brown, Jennifer R. Benson, Don M. Byrd, John C. Peterman, Sissy Cho, Yoonjin Yu, Albert Godfrey, Wayne R. Wagner-Johnston, Nina D.